134 related articles for article (PubMed ID: 36202346)
1. A standardised methodology for the extraction and quantification of cell-free DNA in cerebrospinal fluid and application to evaluation of Alzheimer's disease and brain cancers.
Takousis P; Devonshire AS; Redshaw N; von Baumgarten L; Whale AS; Jones GM; Fernandez-Gonzalez A; Martin J; Foy CA; Alexopoulos P; Huggett JF; Perneczky R
N Biotechnol; 2022 Dec; 72():97-106. PubMed ID: 36202346
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of commercial kits for purification of circulating free DNA.
Diefenbach RJ; Lee JH; Kefford RF; Rizos H
Cancer Genet; 2018 Dec; 228-229():21-27. PubMed ID: 30553469
[TBL] [Abstract][Full Text] [Related]
3. Comparison of paired cerebrospinal fluid and serum cell-free mitochondrial and nuclear DNA with copy number and fragment length.
Chen A; Li J; Wang L; Huang Q; Zhu J; Wen S; Lyu J; Wu W
J Clin Lab Anal; 2020 Jun; 34(6):e23238. PubMed ID: 32052892
[TBL] [Abstract][Full Text] [Related]
4. Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification.
Devonshire AS; Whale AS; Gutteridge A; Jones G; Cowen S; Foy CA; Huggett JF
Anal Bioanal Chem; 2014 Oct; 406(26):6499-512. PubMed ID: 24853859
[TBL] [Abstract][Full Text] [Related]
5. Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples.
Nesic M; Bødker JS; Terp SK; Dybkær K
Biomed Res Int; 2021; 2021():5585148. PubMed ID: 34307658
[TBL] [Abstract][Full Text] [Related]
6. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
Chen L; Shen Q; Xu S; Yu H; Pei S; Zhang Y; He X; Wang Q; Li D
J Alzheimers Dis; 2022; 85(2):573-585. PubMed ID: 34864677
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
[TBL] [Abstract][Full Text] [Related]
8. Extraction of Cell-Free DNA: Evaluation of Efficiency, Quantity, and Quality.
Terp SK; Pedersen IS; Stoico MP
J Mol Diagn; 2024 Apr; 26(4):310-319. PubMed ID: 38336350
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Four Commercial Kits for Isolation of Urinary Cell-Free DNA and Sample Storage Conditions.
Lee EY; Lee EJ; Yoon H; Lee DH; Kim KH
Diagnostics (Basel); 2020 Apr; 10(4):. PubMed ID: 32325682
[TBL] [Abstract][Full Text] [Related]
10. Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA.
Deleu J; Schoofs K; Decock A; Verniers K; Roelandt S; Denolf A; Verreth J; De Wilde B; Van Maerken T; De Preter K; Vandesompele J
Hum Genomics; 2022 Dec; 16(1):73. PubMed ID: 36587211
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.
Niemantsverdriet E; Goossens J; Struyfs H; Martin JJ; Goeman J; De Deyn PP; Vanderstichele H; Engelborghs S
J Alzheimers Dis; 2016; 51(1):97-106. PubMed ID: 26836187
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Evaluation and Application of a Novel Method to Isolate Cell-Free DNA Derived From Bile of Biliary Tract Cancer Patients.
Shen N; Zhu B; Zhang W; Nian B; Xu X; Yu L; Ruan X; Chen S; Liu Y; Cao X; Shi X; Li Z; Huang X; Wang X; Chen C; Xiong L; Zhang D; Fu X; Zhang Y
Front Oncol; 2022; 12():891917. PubMed ID: 35600407
[TBL] [Abstract][Full Text] [Related]
13. A Synthetic DNA Construct to Evaluate the Recovery Efficiency of Cell-Free DNA Extraction and Bisulfite Modification.
Goh SK; Cox DRA; Wong BKL; Musafer A; Witkowski T; Do H; Muralidharan V; Dobrovic A
Clin Chem; 2021 Sep; 67(9):1201-1209. PubMed ID: 34151944
[TBL] [Abstract][Full Text] [Related]
14. Analytical Comparison of Methods for Extraction of Short Cell-Free DNA from Urine.
Oreskovic A; Brault ND; Panpradist N; Lai JJ; Lutz BR
J Mol Diagn; 2019 Nov; 21(6):1067-1078. PubMed ID: 31442674
[TBL] [Abstract][Full Text] [Related]
15. Screening system for epidermal growth factor receptor mutation detection in cytology cell-free DNA of cerebrospinal fluid based on assured sample quality.
Kawahara A; Abe H; Murata K; Ishii H; Azuma K; Takase Y; Hattori S; Naito Y; Akiba J
Cytopathology; 2019 Mar; 30(2):144-149. PubMed ID: 30471155
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal Fluid Mitochondrial DNA in Rapid and Slow Progressive Forms of Alzheimer's Disease.
Podlesniy P; Llorens F; Puigròs M; Serra N; Sepúlveda-Falla D; Schmidt C; Hermann P; Zerr I; Trullas R
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878083
[TBL] [Abstract][Full Text] [Related]
17. A Comparison of Cell-Free DNA Isolation Kits: Isolation and Quantification of Cell-Free DNA in Plasma.
Sorber L; Zwaenepoel K; Deschoolmeester V; Roeyen G; Lardon F; Rolfo C; Pauwels P
J Mol Diagn; 2017 Jan; 19(1):162-168. PubMed ID: 27865784
[TBL] [Abstract][Full Text] [Related]
18. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cell-free DNA as a diagnostic marker in cerebrospinal fluid of dogs.
Stark AC; McGrath S; Karn M; Thomson CE
Am J Vet Res; 2020 May; 81(5):416-421. PubMed ID: 32343180
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.
Beadell AV; Zhang Z; Capuano AW; Bennett DA; He C; Zhang W; Arvanitakis Z
J Alzheimers Dis; 2023; 93(3):1135-1151. PubMed ID: 37182870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]